The pharmacokinetics of remoxipride and metabolites in patients with various degrees of renal function.
@article{MovinOsswald1993ThePO, title={The pharmacokinetics of remoxipride and metabolites in patients with various degrees of renal function.}, author={G. Movin-Osswald and J. Boelaert and M. Hammarlund-Udenaes and L. Nilsson}, journal={British journal of clinical pharmacology}, year={1993}, volume={35 6}, pages={ 615-22 } }
1. The pharmacokinetics of remoxipride, a new neuroleptic, were investigated in an open study with three parallel groups. Twenty-one patients with severely impaired (ClCr < 25 ml min-1), moderately impaired (ClCr 25-50 ml min-1) and normal (ClCr > 65 ml min-1) renal function were evaluated. A single oral dose of remoxipride hydrochloride 100 mg was administered, and blood and urine were collected over 48 h. Concentrations of remoxipride and metabolites were measured by h.p.l.c. 2. In patients… CONTINUE READING
Topics from this paper
10 Citations
Revealing the Neuroendocrine Response After Remoxipride Treatment Using Multi-Biomarker Discovery and Quantifying It by PK/PD Modeling
- Chemistry, Medicine
- The AAPS Journal
- 2016
- 12
- PDF
HUMAN ALPHA-1-GLYCOPROTEIN AND ITS INTERACTIONS WITH DRUGS†,‡
- Chemistry, Medicine
- Drug metabolism reviews
- 2001
- 289
Pharmacology of the atypical antipsychotic remoxipride, a dopamine D2 receptor antagonist.
- Medicine
- CNS drug reviews
- 2001
- 20
- PDF
Interaction of antidepressant and antipsychotic drugs with the human organic cation transporters hOCT1, hOCT2 and hOCT3
- Chemistry, Medicine
- Naunyn-Schmiedeberg's Archives of Pharmacology
- 2012
- 36
Measurement and Analysis of Unbound Drug Concentrations
- Chemistry, Medicine
- Clinical pharmacokinetics
- 1996
- 177
Physiological scaling factors and mechanistic models for prediction of renal clearance from in vitro data
- Chemistry
- 2016
- 1
Age-Related Changes in Protein Binding of Drugs
- Chemistry, Medicine
- Clinical pharmacokinetics
- 2000
- 143
- PDF
References
SHOWING 1-10 OF 10 REFERENCES
Remoxipride: pharmacokinetics and effect on plasma prolactin.
- Chemistry, Medicine
- British journal of clinical pharmacology
- 1991
- 16
Pharmacokinetics and Effects of Propranolol in Terminal Uraemic Patients and in Patients Undergoing Regular Dialysis Treatment
- Medicine
- Clinical pharmacokinetics
- 1976
- 153
Disposition of remoxipride in different species. Species differences in metabolism.
- Biology, Medicine
- Arzneimittel-Forschung
- 1993
- 46
A controlled dose‐ranging study of remoxipride and haloperidol in schizophrenia ‐ a Canadian multicentre trial
- Psychology, Medicine
- Acta psychiatrica Scandinavica. Supplementum
- 1990
- 41
Increased plasma protein binding of propranolol and chlorpromazine mediated by disease-induced elevations of plasma alpha1 acid glycoprotein.
- Medicine
- The New England journal of medicine
- 1978
- 312
Clinical profile of remoxipride ‐ a combined analysis of a comparative double‐blind multicentre trial programme
- Psychology, Medicine
- Acta psychiatrica Scandinavica. Supplementum
- 1990
- 126
Extensive tubular secretion and reabsorption of creatinine in humans.
- Medicine
- Scandinavian journal of urology and nephrology
- 1988
- 50
Determination of remoxipride in plasma and urine by reversed-phase column liquid chromatography.
- Chemistry, Medicine
- Journal of chromatography
- 1990
- 28